Organization’s Name: Sloan Kettering (in ,000’s)
Fin Statement Field 2016 2015
Benefit Expense $458,454 $457,287
Cash & Cash Equivalents $698,872 $422,330
Current Assets $1,671,295 $1,551,944
Current Liabilities $800,605 $724,248
Depreciation and Amortization Expense $263,964 $232,866
Excess of Revenues over Expenses $178,170 $169,169
Interest Expense $48,724 $49,401
Long-term debt $2,544,709 $2,476,950
Long-term Investments $3,140,818 $3,284,853
Marketable Securities $177,868 $242,330
Net Assets $5,730,977 $5,533,963
Net Patient Accounts Receivable $499,284 $613,285
Net Patient Revenues $2,564,674 $2,309,175
Net Receivables $499,284 $613,285
Operating Expense $3,802,192 $3,506,316
Operating Income (also use as net income) $300,498 $174,100
Principal Payments $0 $0
Salary Expense $1,746,943 $1,340,706
Total Assets $9,891,492 $8,040,077
Total Operating Expense $3,802,192 $3,506,316
Total Operating Revenues $3,980,362 $3,675,485
Net Cash from Operating Activities $300,498 $174,100
Net Cash from Investing Activities $116,114 $605,027
Net Cash from Financing Activities $92,158 $506,536
Using the shortened financial statement for Memorial Sloan Kettering Cancer Center (above)
What is the 2016 total cash from these three parts of the cash flow statement.
What is the percentage of net cash from each of the following:
Operating activities:
Investing activities:
Financing activities
Total Cash from Cash Flow Statement: